Clinical Trials Browser

Phase 1/2 × INDUSTRY × LY2940680 × Clear all

NCT01722292 2018-12-28

A Study of LY2940680 in Small Cell Lung Cancer

Phase 1/2 Terminated

26 enrolled 19 charts

Small Cell Lung Carcinoma